Abstract
Germinal Centres (GCs) are transient structures in secondary lymphoid organs, where affinity maturation of B cells takes place following an infection. While GCs are responsible for protective antibody responses, dysregulated GC reactions are associated with autoimmune disease and B cell lymphoma. Typically, 'normal' GCs persist for a limited period of time and eventually undergo shutdown. In this review, we focus on an important but unanswered question - what causes the natural termination of the GC reaction? In murine experiments, lack of antigen, absence or constitutive T cell help leads to premature termination of the GC reaction. Consequently, our present understanding is limited to the idea that GCs are terminated due to a decrease in antigen access or changes in the nature of T cell help. However, there is no direct evidence on which biological signals are primarily responsible for natural termination of GCs and a mechanistic understanding is clearly lacking. We discuss the present understanding of the GC shutdown, from factors impacting GC dynamics to changes in cellular interactions/dynamics during the GC lifetime. We also address potential missing links and remaining questions in GC biology, to facilitate further studies to promote a better understanding of GC shutdown in infection and immune dysregulation.
Introduction: The Mystery of the GC "Off-Switch"
Germinal Centres are transient "pop-up" structures in lymph nodes where B cells undergo rapid mutation and selection to create high-affinity antibodies. While the formation and function of GCs are well-documented, the mechanisms governing their natural dissolution remain poorly understood. In a healthy immune response, GCs typically dissolve after a few weeks. Persistent or chronic GCs pose significant risks, including the production of auto-antibodies or transformation into B-cell lymphomas. Conversely, premature shutdown results in weak, ineffective antibody responses. This review synthesizes current research to address a fundamental question: What biological signals primarily drive the natural termination of the GC reaction?
Synthesis Approach
This review employs a multidisciplinary synthesis of existing literature and computational perspectives. The authors analyzed over 200 studies, ranging from murine experiments to clinical observations of human lymphomas. They also integrate computational modeling to simulate GC dynamics that are difficult to observe in vivo, such as the recycling probability of B cells between different GC zones. By comparing transient "normal" GCs with chronic viral-induced GCs and constitutive GCs in the gut, the authors identify potential factors that maintain or stall the GC "engine."
Mechanisms of Termination
Rather than a single "off switch," the authors propose a multi-factorial environment that triggers shutdown through coordinated cellular and metabolic shifts.
1. Antigen Limitation and Feedback
As B cells successfully produce high-affinity antibodies, these antibodies may bind to remaining antigens on Follicular Dendritic Cells (FDCs), effectively "masking" them. This creates a negative feedback loop where the success of the GC leads to its own starvation of survival signals.
2. T-Cell Signal Shifting
T follicular helper (Tfh) cells provide essential survival signals like CD40L and IL-21. Evidence suggests a late-stage shift from IL-21 to IL-4 production, which may signal B cells to differentiate into plasma cells or memory B cells and exit the GC rather than continuing the mutation cycle.
3. Metabolic Exhaustion and Structural Changes
GC B cells rely heavily on fatty acid oxidation. The authors hypothesize that as the GC matures, local fatty acid reserves may be exhausted, leading to a metabolic "crash" and subsequent apoptosis. Additionally, FDCs undergo morphological changes that may physically sequester remaining antigens in membrane pockets, further limiting B cell access.
Discussion: Limitations and Future Directions
Despite identifying several potential triggers, the primary driver of natural GC termination in healthy infections remains elusive. Current knowledge is heavily weighted toward "loss-of-function" studies (e.g., knocking out BAFF or CD40L), which demonstrate what is required for maintenance rather than what actively triggers shutdown.
Future research must overcome the observational challenges of tracking stochastic GC development in vivo. The authors advocate for more "gain-of-function" studies to identify signals that can extend GC lifespan, which would provide deeper insights into the maintenance-to-termination transition. Bridging these mechanistic gaps is crucial for developing treatments for ectopic GCs associated with autoimmune diseases like Rheumatoid Arthritis.
Summary updated